Two treatments were used in this study: a gel containing 0.5 mg/g betamethasone dipropionate (BDP) and a cream containing 2.5 mg/g LEO 29102, a PDE4 inhibitor which showed efficacy in a four week psoriasis plaque study (NCT00875277). Here, PDE4A is linked to psoriasis.